SR ONE CAPITAL MANAGEMENT, LP - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
SR ONE CAPITAL MANAGEMENT, LP ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,168,773
-43.6%
4,012,9030.0%7.77%
-32.9%
Q2 2023$26,886,450
+2.9%
4,012,9030.0%11.59%
+19.1%
Q1 2023$26,123,999
+1.8%
4,012,903
+33.3%
9.73%
+3.8%
Q4 2022$25,672,5443,009,6779.37%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,618,036$80,871,0003.02%
Orbimed Advisors 8,740,887$270,006,0002.73%
Boxer Capital, LLC 1,675,377$51,752,0001.83%
Endurant Capital Management LP 139,124$4,298,0001.18%
Nantahala Capital Management 1,266,266$39,115,0001.11%
COMMODORE CAPITAL LP 97,143$3,001,0001.05%
Ally Bridge Group (NY) LLC 128,572$3,972,0000.99%
RA Capital Management 1,742,186$53,816,0000.86%
HighVista Strategies LLC 25,906$800,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 173,891$5,371,0000.36%
View complete list of SILVERBACK THERAPEUTICS INC shareholders